Report Highlights
The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Report Includes
- 38 data tables and 33 additional tables
- An overview of the global market for medical robotics and computer-assisted surgery (MRCAS)
- Analysis of global market trends, featuring historical revenue data for 2020-2023, forecasts for 2028, and projections of compound annual growth rates (CAGRs) through 2028
- Evaluation of the current market’s size and revenue growth prospects specific to MRCAS, along with a market share analysis by product, application, end user and geographic region
- A look at emerging technology trends, gaps and opportunities in the market estimating current and future demand for MRCAS, and identification of the companies best positioned to meet this demand
- Facts and figures pertaining to market drivers and restraints, as well as ESG trends
- Identification of promising new surgical procedures and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
- Impact of COVID-19 on the MRCAS market.
- Insight into the growth development strategies of major MRCAS manufacturers
- Information on latest industry developments, including R&D, emerging technologies and economic trends
- Market share analysis for the key companies of the industry and coverage of their proprietary technologies, patents, and strategic alliances and other market strategies
- Profiles of the leading companies in the industry, including Intuitive Surgical Operations Inc., Medtronic, Stryker, and Zimmer Biomet
Report Scope
This goal of this report is to study the global market for medical robotics and computer-assisted surgery, and determine its size by estimating current revenues by product, indication, end user and region.
Report Synopsis
Report Metrics | Details | ||||||||
---|---|---|---|---|---|---|---|---|---|
Base year considered | 2022 | ||||||||
Forecast period considered | 2023-2028 | ||||||||
Base year market size | $10.4 billion | ||||||||
Market size forecast | $19.5 billion | ||||||||
Growth rate | CAGR of 11.0% for the forecast period of 2023-2028 | ||||||||
Units considered | $ Millions | ||||||||
Segments covered | Product Type, Application, End User, and Region | ||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||
Key Market Drivers |
|
||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for surgical robotics and computer-assisted surgery should grow from $6.1 billion in 2020 to $11.6 billion by 2025 with a compound annual growth rate (CAGR) of 13.5% for the period of 2020-2025.
Report Includes
- 42 tables
- An up-to-date analysis of the global medical robotics and computer-assisted surgery (MRCAS) market
- Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2025
- Estimation of market size and revenue forecast for global MRCAS market, and corresponding market share analysis by type, application (disease), and region for each market segment
- Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for MRCAS, identification of the companies that are best positioned to meet this demand
- In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market
- Identification of promising new surgical procedures and products still in the development and testing stages, and their probability of successful commercial launch within the next five years
- Impact of COVID-19 on the medical robotics and computer-assisted surgery market as compared to overall global economy
- Insight into the growth development strategies of major MRCAS manufacturers and their key competitive landscape
- Descriptive company profiles of the leading market participants, including Medtech Global Ltd., Siemens AG, Zimmer Biomet Holding Inc., Titan Medical Inc., Panasonic Corp. and Hitachi Ltd.
Report Highlights
The global surgical robotics and computer-assisted surgery market reached nearly $3.5 billion in 2015. This market is expected to increase from $4.0 billion in 2016 to $6.8 billion in 2021 at a compound annual growth rate (CAGR) of 11.3% for 2016-2021.
Report Includes
- An overview of the global market for medical robotics and computer-assisted surgery (MRCAS).
- Analyses of global market trends, with data from 2015 and 2016, and projections of CAGRs through 2021.
- Examination of the historical and current value of each of the product segments in specified applications and geographical markets.
- Evaluation of the impact of demographic, economic, and other factors that will drive future demand for MRCAS devices.
- Identification of promising new surgical procedures and products still in the development and testing stages, and the probability that they will be commercialized successfully within the next five years.
- Profiles of major players in the industry.
Report Highlights
The global market for medical robotics and computer-assisted surgical (MRCAS) equipment was worth nearly $2.7 billion in 2013. The market is projected to approach $3.3 billion in 2014 and $4.6 billion by 2019 for a CAGR of 7% for the five-year period, 2014 to 2019.
Report Includes
- An overview of the global market for medical robotics and computer-assisted surgery (MRCAS).
- Analyses of global market trends, with data from 2013, estimates for 2014, and projections of CAGRs through 2019.
- Examination of the historical and current value of each of the product segments in specified applications and geographical markets.
- Evaluation of the impact of demographic, economic, and other factors that will drive future demand for MRCAS devices.
- Identification of promising new surgical procedures and products still in the development and testing stage, and and the probability that they will be commercialized successfully within the next five years.
Report Highlights
The global MRCAS market was valued at nearly $2.2 billion in 2011 and should reach nearly $2.4 billion in 2012. Total market value is expected to reach nearly $4 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 10.6%.
Report Highlights
The global market for medical robotics and computer-assisted surgical equipment was worth nearly $2 billion in 2010. The market is projected to be $2.1 billion in 2011 and $3.6 billion by 2016 for a CAGR of 11.1% between 2011 and 2016.
Report Highlights
- The U.S. market for medical robotics and computer-assisted surgical equipment was worth an estimated $648 million in 2008. The market is projected to reach $676 million in 2009 and $1.5 billion by 2014, a CAGR of 17.7%.
- Surgical robot systems were the largest product segment of the market in 2008 with a 54% market share. With a projected average annual growth rate of more than 23% between 2009 and 2014, surgical robots are expected to increase their share of the US MRCAS market to 65% by 2014.
- In terms of surgical applications, orthopedic surgical applications are projected to grow at a CAGR of 42.6% between 2009 and 2014, and are expected to account for 22% of the market by 2014.
Report Highlights
-
The U.S. market for medical robotics and computer-assisted surgical equipment was worth an estimated $564 million in 2005. The market is projected to reach $704 million in 2006 and $2.8 billion by 2011, an average annual growth rate (AAGR) of 31.4%.
-
Surgical navigation systems were the largest product segment (53%) of the U.S. MRCAS market in 2005. However, surgical robots are the fastest growing U.S. market segment, with a projected AAGR of over 43% between 2006 and 2011.
-
In terms of surgical applications, neurosurgical applications accounted for the bulk of the U.S. MRCAS market-approximately 40%-in 2005. Endoscopic surgical applications are the fastest-growing application segment, and are expected account for a market-leading 45% of the U.S. market by 2011.
-
The total worldwide market for MRCAS devices and equipment is expected to be $1.3 billion in 2006 and $5.7 billion by 2011, an AAGR of 34.7%.
Report Highlights
-
U.S. MRCAS market will grow at more than 22% annually on average reaching $673 million by 2007.
-
Surgical robots are the fastest-growing U.S market segment.
-
Sales of surgical robots should reach $220 million in 2007.
-
Endoscopic surgical applications are the fastest-growing application segment.
Related Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Microelectronic Medical Implants: Products, Technologies & Opportunities
The global market for microelectronic medical implants is expected to grow from $49.0 billion in 2024 and is projected to reach $85.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.7% during the forecast period of 2024 to 2029.
Robotics: Technologies and Global Markets
The global market for robotics was valued at $67.9 billion in 2023. The market is expected to grow from $78.4 billion in 2024 to $165.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 16.1% from 2024 to 2029.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More